Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-25-049687
Filing Date
2025-06-02
Accepted
2025-06-02 07:41:07
Documents
117
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT ea0244122-10k_onconetix.htm   iXBRL 10-K 2484133
2 DESCRIPTION OF REGISTERED SECURITIES ea024412201ex4-2_onconetix.htm EX-4.2 26073
3 INSIDER TRADING POLICY, ADOPTED AUGUST 7, 2023 ea024412201ex19_onconetix.htm EX-19 81205
4 LIST OF SUBSIDIARIES ea024412201ex21_onconetix.htm EX-21 2804
5 CONSENT OF MALONE BAILEY ea024412201ex23-1_onconetix.htm EX-23.1 2051
6 CONSENT OF EISNERAMPER LLP ea024412201ex23-2_onconetix.htm EX-23.2 2201
7 CERTIFICATION ea024412201ex31-1_onconetix.htm EX-31.1 12038
8 CERTIFICATION ea024412201ex32-1_onconetix.htm EX-32.1 4826
9 POLICY RELATED TO RECOVERY OF ERRONEOUSLY AWARDED COMPENSATION, ADOPTED JANUARY ea024412201ex97_onconetix.htm EX-97 18123
10 GRAPHIC image_001.jpg GRAPHIC 103099
11 GRAPHIC image_002.jpg GRAPHIC 52488
12 GRAPHIC image_003.jpg GRAPHIC 49206
13 GRAPHIC image_004.jpg GRAPHIC 61595
14 GRAPHIC ex19_001.jpg GRAPHIC 4586
  Complete submission text file 0001213900-25-049687.txt   13385888

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE onco-20241231.xsd EX-101.SCH 118957
16 XBRL CALCULATION FILE onco-20241231_cal.xml EX-101.CAL 101622
17 XBRL DEFINITION FILE onco-20241231_def.xml EX-101.DEF 628161
18 XBRL LABEL FILE onco-20241231_lab.xml EX-101.LAB 1154125
19 XBRL PRESENTATION FILE onco-20241231_pre.xml EX-101.PRE 660840
120 EXTRACTED XBRL INSTANCE DOCUMENT ea0244122-10k_onconetix_htm.xml XML 1380707
Mailing Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202
Business Address 201 E. FIFTH STREET SUITE 1900 CINCINNATI OH 45202 513-620-4101
Onconetix, Inc. (Filer) CIK: 0001782107 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-41294 | Film No.: 251013155
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)